Transmission electron microscopes (TEMs) allow researchers at the forefront of energy technology to study next-generation battery materials down to ...
Investing.com -- Shares of drug developer Eikon Therapeutics (NYSE:EIKN) rose 6% to $14.65 on Monday as at least five Wall Street brokerages initiated coverage with bullish ratings following the end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results